Drugs of Abuse Testing: Technologies and Global Markets

Published - Apr 2019| Code - PHM013H| Analyst - BCC Research Staff

Report Highlights

The global market for drugs of abuse (DOA) testing should grow from $3.5 billion in 2018 to $4.6 billion by 2023 with a compound annual growth rate (CAGR) of 5.6% for the period of 2018-2023.

Report Includes

  • 32 data tables and 49 additional tables
  • An industry analysis of the global market for drug testing technologies within the pharmaceutical industry
  • Analyses of global market trends, with data from 2017, 2018 and projections of compound annual growth rates (CAGRs) through 2023
  • Statistical information pertaining to drug abuse along with its trends as well as drug classes in key geographic regions
  • Information on leading players in the market and their key products
  • Sales projections through 2023 for drug of abuse testing markets by sample matrix and geographic regions
  • Technological assessment of the current and possible future legislation affecting the market in the U.S. and other emerging economies, and examines the influence of these acts in the development of the industry
  • Company profiles of major global players operating within the drug development market, including Ortho-Clinical Diagnostics, Randox Toxicology, F. Hoffmann-La Roche Ltd., Siemens Healthineers, Thermo Fisher Scientific Inc., Quest Diagnostics, and Abbott Laboratories

Report Scope

The report includes the following:

  • An overview of the technologies, types and significance of DOA testing technologies across the globe
  • Drug abuse statistics in key regions.
  • An analysis of regulatory environments in the North America, Europe and Asia-Pacific regions, with country-specific summaries of national legislation and policies.
  • Technology trends in the DOA testing market.
  • Market size and forecast data by region through 2023 for the DOA testing market.
  • Market size and forecast data by sample matrix through 2023 for the DOA testing market.
  • Market size and forecast data through 2023 by test type (laboratory-based and onside) for the DOA testing market.
  • A patent analysis of equipment and technology related to DOA testing.
  • A description of the competitive landscape for DOA testing, including a company share analyses and ranking and the key strategies of leading market players.
  • Company profiles of leading players in the DOA testing market and their key products.
  • An analysis of leading companies and their successful strategies.

The report excludes the following:

  • Alcohol testing and equipment and devices related to alcohol abuse testing are not covered.
  • Market sizing data does not include sales of breath analyzers.

Analyst Credentials

BCC Research staff comprises expert analysts who are skilled in conducting primary research, secondary research and data analysis and have decades of combined experience covering a wide range of industries, including healthcare, advanced materials and emerging technologies. Collectively, the team represents a diverse set of educational achievements with individual graduate work completed in fields such as microbiology, electrical engineering, business administration and surgery, among others.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Note: Reports are discounted or included with certain Memberships. See Membership Options.
Title/Chapter Name Pages Price Member Price
Full Report: Drugs of Abuse Testing: Technologies and Global Markets 174 $5,500 Free
Chapter- 1: Introduction5Free DownloadFree
Chapter- 2: Summary and Highlights3$250Free
Chapter- 3: Market and Technology Background27$853Free
Chapter- 4: Market Dynamics17$537Free
Chapter- 5: Regulatory Scenario32$1,011Free
Chapter- 6: Global Drugs of Abuse Testing Market by Sample Type13$411Free
Chapter- 7: Global Drugs of Abuse Testing Market by Region19$601Free
Chapter- 8: Global Drugs of Abuse Testing Market by Testing Type2$63Free
Chapter- 9: Patent Analysis2$63Free
Chapter- 10: Competitive Landscape8$253Free
Chapter- 11: Company Profiles44$1,391Free
Chapter- 12: Acronyms2$63Free
Published - May-2017| Analyst - Jon Evans| Code - PHM013G

Report Highlights

The global drug of abuse (DOA) testing market reached nearly $3.0 billion in 2016. This market is estimated to grow at a compound annual growth rate (CAGR) of 4.5% to reach nearly $3.9 billion by 2022 from $3.1 billion in 2017.

Report Includes

  • An overview of the global market for drug testing technologies.
  • Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • An overview of drug abuse trends in terms of various geographic regions as well as drug classes.
  • Information on leading players in the market and their key products.
  • Analysis of leading companies in the field and their successful strategies.
Published - Mar-2015| Analyst - Jon Evans| Code - PHM013F

Report Highlights

The global drug of abuse (DOA) testing market reached nearly $2.8 billion in 2014. This market is estimated to grow at a compound annual growth rate (CAGR) of 4.5% to reach almost $3.5 billion by 2019.

Report Includes

  • An overview of the global market for drug testing technologies.
  • Analyses of global market trends, with data from 2013, estimates for 2014, and projections of CAGRs through 2019.
  • An overview of drug abuse trends in terms of various geographic regions as well as drug classes.
  • Information on leading players in the market and their key products.
  • Analysis of leading companies in the field and their successful strategies.

Published - Jul-2008| Analyst - Syamala Ariyanchira| Code - PHM013E

Report Highlights

  • The global market for DOA testing increased from $1.9 billion in 2007 to an estimated $2.0 billion by the end of 2008. It should reach $2.6 billion in 2014, for a compound annual growth rate (CAGR) of 4.6%.
  • The U.S. testing market segment generated the largest share of revenues with $1.4 billion in 2007. This is expected to reach $1.5 billion in 2008 and $2.0 billion in 2014, for a CAGR of 5.2%.
  • The European Union had the second largest market segment with $365.2 million in sales in 2007. This is expected to grow at a CAGR of 2.9% to reach $374.2 million in 2008 and $445.9 million in 2014.
Published - Jul-2002| Analyst - Ruth Scolnick| Code - PHM013D

Report Highlights

  • Drugs of abuse testing sales will reach $1.6 billion in 2007, rising at an AAGR (average annual growth rate) of 4.7%.
  • Sales in the U.S. are expected to reach $996 million in 2002 and forecasted to grow to $1.3 billion in 2007 at an AAGR of 5.4%.
  • Sales in Europe expected to be $291 million in 2002 and forecasted to grow at an AAGR of 1.8% to approximately $318 million in 2007.
  • The number of different places and applications, such as a workplace, drug court, hospital, and school, for drug testing, with blood, hair, oral fluid, sweat or urine samples, reflects the need for a variety of drug testing services and the versatility of drug testing technology.

RELATED REPORTS
Share This Report